-

Verily Health Awarded Centers for Disease Control and Prevention Contract to Support National Infectious Disease Wastewater Surveillance

Broader pathogen testing, genomic sequencing, and metagenomic capabilities under new agreement

DALLAS--(BUSINESS WIRE)--Verily Health Inc., a healthcare data intelligence company, announced today that it has been awarded a contract by the Centers for Disease Control and Prevention (CDC) to continue supporting the national wastewater-based infectious disease surveillance program, building on the work that the company has performed for the CDC since 2023.

Under the new award, Verily Health will support CDC's National Wastewater Surveillance System through Verily Sightline, combining wastewater science, laboratory testing, data analytics, and technology to track infectious disease trends and support public health decision-making. The expanded program will continue pathogen testing, pathogen genomic sequencing, and include potential metagenomic capabilities, giving public health officials additional tools to monitor infectious diseases and respond to emerging threats.

"We're proud to continue our work with the CDC on a program that strengthens national public health surveillance," said Stephen Gillett, Chairman and CEO of Verily Health. "At Verily Health, we are building the data foundation for the future of healthcare intelligence, bringing together complex health data, scientific expertise, and advanced analytics to generate actionable insights that accelerate research and improve healthcare."

About Verily Health Inc.

At the intersection of technology, data science, and healthcare, Verily Health transforms complex health data into trusted intelligence, enabling health solutions that are more personal, predictive, and precise.

Verily’s flagship Governed Health Intelligence platform, Verily Pre, enables healthcare organizations to responsibly govern, model, and securely activate their protected health data at scale, deploying intelligence with the scientific rigor, oversight, and auditability needed for healthcare.

For more information about Verily Health, please visit verily.com.

Contacts

Media Contact:
Laurie Ferguson
VP Communications
verily-press@verily.com

Industry:

Verily Health Inc.

Release Versions
English

Contacts

Media Contact:
Laurie Ferguson
VP Communications
verily-press@verily.com

More News From Verily Health Inc.

Verily Health Selected to Build Data Platform for ARPA-H CIRCLE Program

DALLAS--(BUSINESS WIRE)--Verily Health Inc., a precision health AI company, today announced it has been selected by the Advanced Research Projects Agency for Health (ARPA-H), an agency within the U.S. Department of Health and Human Services, to serve as an Acceleration Platform performer for the agency's Critical Illness Immunological Reprogramming and Control Point Learning Engine (CIRCLE) program. In this role, Verily Health will build and operate the shared program database that CIRCLE's res...

Verily Health Secures New Investment From NVIDIA and CU Healthcare Innovation Fund

DALLAS--(BUSINESS WIRE)--Verily Health Inc. today announced it has received investment support from NVIDIA, as Verily extends its March fundraising. Existing investor CU Healthcare Innovation Fund II, LP is also making an additional investment. Verily’s current investors include Alphabet, Series X Capital, UCHealth, and others. "We are pleased to welcome NVIDIA as a new investor in Verily. These investments strengthen our ability to pursue the opportunity ahead. Together, these investments and...
Back to Newsroom